STADA Arzneimittel AG 23.06.2014 09:16 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of voting rights pursuant to Art. 25, Sec. 1 WpHG We received the following notification pursuant to Art. 25, Sec. 1 WpHG on June 19, 2014: 1. Listed company: STADA Arzneimittel AG StadastraÃe 2-18, 61118 Bad Vilbel, Deutschland 2. Notifier: The Goldman Sachs Group, Inc., Wilmington, Delaware, USA 3. Triggering event: Falling below threshold 4. Threshold(s) crossed or reached: 5% 5. Date at which the threshold is crossed or reached: 16.06.2014 6. Total amount of voting rights: 0.60% (equals 362745 voting rights) 7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to sec. 25 WpHG: 0.18% (equals 110616 voting rights) thereof held indirectly: 0.18% (equals 110616 voting rights) Voting rights pursuant to sec. 21, 22 WpHG: 0.42% (equals 252129 voting rights) 8. Detailed information on financial/other instruments pursuant to sec. 25 WpHG: Chain of controlled undertakings: 1) Goldman Sachs (UK) L.L.C., Goldman Sachs Group UK Limited, Goldman Sachs Group Holdings (U.K.) Limited, Goldman Sachs Holdings (U.K.), Goldman Sachs International, 2) Goldman, Sachs & Co. ISIN or name/description of the financial/other instrument: Stock Loan (Physical) Exercise period: Maturity: Expiration date: 23.06.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Germany Internet: www.stada.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG